Azusa Nagao Shoko Nakazawa Hideji Hanabusa
10.1186/1756-8722-7-10
J Hematol Oncol
2014 Jan 17;7:10.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24438824/
Antibodies, Monoclonal, Humanized / therapeutic use Castleman Disease / drug therapy HIV Infections / complications Receptors, Interleukin-6 / antagonists & inhibitors
Antibodies, Monoclonal, Humanized / therapeutic use Castleman Disease / drug therapy HIV Infections / complications Receptors, Interleukin-6 / antagonists & inhibitors Case Reports Adult Antibodies, Monoclonal, Humanized / immunology Castleman Disease / complications Castleman Disease / metabolism Humans Male Middle Aged Receptors, Interleukin-6 / immunology Receptors, Interleukin-6 / metabolism Recurrence Time Factors Treatment Outcome Antibodies, Monoclonal, Humanized Receptors, Interleukin-6 tocilizumab Multi-centric Castleman's Disease
PMC3896700
24438824
Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases
2014